Ptc Therapeutics
PTCT
Ptc Therapeutics (PTCT) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| RBC Capital | Maintained | Sector Perform | $75.00 from $85.00 | Oct 8, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $137.00 from $130.00 | Sep 22, 2026 |
| Leerink Partners | Initiated Coverage | Outperform | $98.00 | Sep 14, 2026 |
| Barclays | Maintained | Overweight | $122.00 from $120.00 | Aug 14, 2026 |
| Wells Fargo | Maintained | Overweight | $109.00 from $106.00 | Aug 13, 2026 |
| Wells Fargo | Maintained | Overweight | $106.00 from $93.00 | Jul 31, 2026 |
| Morgan Stanley | Maintained | Overweight | $104.00 from $93.00 | Jul 31, 2026 |
| Wells Fargo | Maintained | Overweight | $93.00 from $95.00 | Jul 20, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $130.00 from $124.00 | Jul 16, 2026 |
| RBC Capital | Maintained | Sector Perform | $85.00 from $82.00 | Jul 7, 2026 |
| Citigroup | Initiated Coverage | Neutral → Buy | $108.00 from $75.00 | Jun 9, 2026 |
| Jefferies | Upgraded | Hold → Buy | $85.00 from $76.00 | May 27, 2026 |
| Wells Fargo | Maintained | Overweight | $95.00 from $86.00 | May 8, 2026 |
| RBC Capital | Maintained | Sector Perform | $82.00 from $81.00 | May 8, 2026 |
| TD Cowen | Upgraded | Hold → Buy | $90.00 from $75.00 | May 8, 2026 |
| Jefferies | Downgraded | Buy → Hold | $76.00 from $91.00 | Mar 30, 2026 |
| Morgan Stanley | Maintained | Overweight | $92.00 from $90.00 | Feb 23, 2026 |
| B of A Securities | Maintained | Buy | $93.00 from $97.00 | Feb 20, 2026 |
| RBC Capital | Maintained | Sector Perform | $82.00 from $87.00 | Feb 20, 2026 |
| Wells Fargo | Maintained | Overweight | $86.00 from $93.00 | Feb 20, 2026 |
Frequently asked questions
What is the latest analyst rating on PTCT?
On Oct 8, 2026, RBC Capital maintained Ptc Therapeutics at Sector Perform with a price target of $75.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.